Structure of enzyme that causes Parkinson’s promises pathways to new drugs
Structural biologists at St. Jude Children’s Research Hospital have determined the detailed structure of an enzyme whose mutated forms are known to cause Parkinson’s disease. The achievement opens a research pathway to develop new drugs that can specifically target the aberrant form of a protein enzyme called LRRK2.
